Market Tracker

10/31 1:50pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

18.88
Real-Time Quote
 +0.44 / +2.39%
Today’s Change
8.57
Today|||52-Week Range
20.29
+102.14%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close18.44
Today’s open18.89
Day’s range18.56 - 19.68
Volume594,743
Average volume (3 months)534,585
Market cap$1.4B
Dividend yield--
Data as of 1:35pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-13.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book10.31

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+3.86+5.48%
USNAUSANA Health Science...+2.80+2.54%
PDLIPDL BioPharma Inc+0.10+1.18%
HZNPHorizon Pharma PLC+0.09+0.71%
Data as of 1:49pm ET, 10/31/2014

Financials

Last reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts